Actos Side Effects
The FDA issued on September 2010 a Drug Safety Community which notes that the five years into a 10-year research of any link between bladder cancer and Actos, a connection had been reveleaed for patients who have been taking for over 24 months, with higher dose of Actos increasing bladder cancer risk even further. On April 2011, the American Diabetes Association made known to the public a study using adverse events report that the FDA made between 2004 and 2009. The study affirmed that data was consistent with the link between Actos and bladder cancer.
On June 2011, the agency issued a stronger and updated warning which stated that even a year of taking the supplement can raise the risk of bladder cancer by over 40% in addition to other Actos side effects. FDA recommended as well that doctors should not prescribe the drug to patients who have history of bladder cancer.
